/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

← → days · ↑ ↓ browse · Enter similar · o open

Chinese health care crowdfunding platform Shuidichou raises ~$74M Series B led by Tencent and says it has raised $1.8B+ across 400M campaigns

China-based healthcare crowdfunding platform Shuidichou has raised nearly 500 million yuan ($74 million) in a Series B funding round led …

DealStreetAsia Ka Kay Lum

Context & Ripple Effects

Shuidichou's Series B is Tencent doubling down on a bet it first made in 2017, when it led the platform's $24M Series A back when Shuidi had helped raise just $140M for some 60,000 patients. The scale-up since then is stark: over $1.8B raised across 400M crowdfunding campaigns, making medical expense crowdfunding one of the highest-volume consumer finance surfaces in Chinese health care.

The round also fits Tencent's pattern of stacking positions across the country's digital health stack — it already backs WeDoctor, which raised $500M at a $5.5B valuation ahead of an IPO, alongside online pharmacy plays like Yaoshibang. Crowdfunding sits at the patient-acquisition end of that stack.

First-order effects

  • Shuidichou gets Tencent-led capital to scale a platform processing hundreds of millions of campaigns, while Tencent extends its grip on the entry point of Chinese digital health — the moment a family faces a medical bill it cannot pay.

Second-order effects

  • Adjacent players in health financing feel the pull: payment-and-pharmacy platforms like MediTrust Health, which raised $308M four months after a $154M Series B, are building the downstream infrastructure that crowdfunded money flows into, tightening the crowdfunding-to-payment pipeline.

Third-order effects

  • If the pattern holds, medical crowdfunding becomes the top-of-funnel for a consolidated digital health financing chain — donor traffic captured by Tencent-backed platforms, monetized through payments, telehealth, and pharmacy — with China's high out-of-pocket treatment costs as the structural driver.

The trend: Tencent is assembling ownership across every layer of China's digital health economy, from crowdfunding and telehealth to online pharmacies and health payments.